![logo](/logos/BLISSGVS.NS.webp)
Bliss GVS Pharma Limited
NSE:BLISSGVS.NS
128.65 (INR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Bliss GVS Pharma Limited |
Symbool | BLISSGVS.NS |
Munteenheid | INR |
Prijs | 128.65 |
Beurswaarde | 13,503,875,900 |
Dividendpercentage | 0.46% |
52-weken bereik | 77.35 - 149.6 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Gagan Harsh Sharma |
Website | https://www.blissgvs.com |
An error occurred while fetching data.
Over Bliss GVS Pharma Limited
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)